Tip - Five Years of Tamoxifen Continues to Benefit Women 15 Years after Treatment

In a large randomized clinical trial, women with early-stage breast cancer who received 5 years of adjuvant treatment with tamoxifen had better outcomes up to 15 years after the start of treatment than those who received 2 years of tamoxifen therapy.
Tags: breast, tamoxifen, Nolvadex, Novaldex